Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

BRCA1 mutations and luminal-basal transformation

Oncogene volume 32, pages 2712–2714 (2013)Cite this article

Subjects

Abstract

The multifunctional roles of BRCA1 include its ability to regulate transcriptional processes that control differentiation at multiple levels, as well as functioning as a tumor suppressor. Data herein demonstrate that germline mutations in Brca1 impair luminal cell lineage and mammary development, with its deficiency converting ER-positive luminal tumors into basal-like cancers. Heterozygous mutations in Brca1 lead to downregulation of a number of luminal differentiation genes, explaining how it suppresses basal-like tumors, also highlighting its importance outside of its known highly publicized role in DNA repair.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Bai F, Smith MD, Chan HL, Pei X-H . Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation. Oncogene 2013; 32: 2715–2725.

    Article  CAS  Google Scholar 

  2. Somasundaram K, Zhang H, Zeng Y-X, Houvras Y, Peng Y, Zhang H et al. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl. Nature 1997; 389: 187–190.

    Article  CAS  Google Scholar 

  3. Molyneux G, Geyer FC, Magnay FA, McCarthy A, Kendrick H, Natrajan R et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 2010; 7: 403–417.

    Article  CAS  Google Scholar 

  4. Pei X-H, Bai F, Smith MD, Usary J, Fan C, Pai S-Y et al. CDK inhibitor p18INK4c is a downstream target of gata3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis. Cancer Cell 2009; 15: 389–401.

    Article  CAS  Google Scholar 

  5. Chen Y, Lee W-H, Chew HK . Emerging roles of BRCA1 in transcriptional regulation and DNA repair. J Cell Physiol 1999; 181: 385–392.

    Article  CAS  Google Scholar 

  6. Taghavi N, Biramijamal F, Sotoudeh M, Khademi H, Malekzadeh R, Moaven O et al. p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma. BMC Cancer 2010; 10: 138.

    Article  Google Scholar 

  7. Drost R, Bouwman P, Rottenberg S, Boon U, Schut E, Klarenbeek S et al. BRCA1 ring function is essential for tumor suppression but dispensable for therapy resistance. Cancer Cell 2011; 20: 797–809.

    Article  CAS  Google Scholar 

  8. Deans AJ, Khanna KK, McNees CJ, Mercurio C, Heierhorst J, McArthur GA . Cyclin-dependent kinase 2 functions in normal dna repair and is a therapeutic target in BRCA1-deficient cancers. Cancer Res 2006; 66: 8219–8226.

    Article  CAS  Google Scholar 

  9. Morris JR, Boutell C, Keppler M, Densham R, Weekes D, Alamshah A et al. The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature 2009; 462: 886–890.

    Article  CAS  Google Scholar 

  10. Coene ED, Gadelha C, White N, Malhas A, Thomas B, Shaw M et al. A novel role for BRCA1 in regulating breast cancer cell spreading and motility. J Cell Biol 2011; 192: 497–512.

    Article  CAS  Google Scholar 

  11. Turner NC, Lord CJ, Iorns E, Brough R, Swift S, Elliott R et al. A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor. EMBO J 2008; 27: 1368–1377.

    Article  CAS  Google Scholar 

  12. Furuta S, Jiang X, Gu B, Cheng E, Chen PL, Lee WH . Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells. Proc Natl Acad Sci USA 2005; 102: 9176–9181.

    Article  CAS  Google Scholar 

  13. Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin GY, Abel KJ et al. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 1995; 11: 17–26.

    Article  CAS  Google Scholar 

  14. Rajan JV, Wang M, Marquis ST, Chodosh LA . Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci USA 1996; 93: 13078–13083.

    Article  CAS  Google Scholar 

  15. Lane TF, Deng C, Elson A, Lyu MS, Kozak CA, Leder P . Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev 1995; 9: 2712–2722.

    Article  CAS  Google Scholar 

  16. Kubista M, Rosner M, Kubista E, Bernaschek G, Hengstschlager M . Brca1 regulates in vitro differentiation of mammary epithelial cells. Oncogene 2002; 21: 4747–4756.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Richard Dimbleby Department of Cancer Research, Randall Division and Division of Cancer Studies, Kings College London, Guy’s Medical School Campus, London, UK

    T Ng & S Irshad

  2. Breakthrough Breast Cancer Research Unit, Research Oncology, King’s College London, Guy’s Medical School Campus, London, UK

    T Ng & S Irshad

  3. Department of Medical Oncology, Imperial College, Hammersmith Campus, London, UK

    J Stebbing

Authors
  1. T Ng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Irshad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Stebbing
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J Stebbing.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ng, T., Irshad, S. & Stebbing, J. BRCA1 mutations and luminal-basal transformation. Oncogene 32, 2712–2714 (2013). https://doi.org/10.1038/onc.2012.379

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2012.379

Search

Advanced search

Quick links